Company President of GM Unloads 13,715 Shares in Insider Sale

Mark L Reuss, the President of $GM, recently sold 13,715 shares of the company on 09-24-2025, amounting to an estimated $823,311. This transaction, disclosed in a recent SEC filing, represented a sale of about 6.0% of his shares in this particular class of stock. Following this sale, Mr. Reuss now holds 214,066 shares of this class of $GM stock.

Analyzing the insider trading activity within $GM, we find that company insiders have executed 20 trades in the last 6 months. Among these transactions, none have been purchases, while all 20 have been sales. To provide a more detailed picture, let’s examine the recent trading of $GM stock by key insiders over this period of time:

– MARY T BARRA, the Chair & CEO, has not made any purchases but has conducted 9 sales, liquidating 1,801,887 shares for an estimated $106,310,172.
– MARK L REUSS, the President, also has not made any purchases but has sold 163,030 shares in 4 transactions, totaling $9,798,282.
– CHRISTOPHER HATTO, Vice President & CAO, has made 0 purchases and executed 3 sales, selling 51,471 shares for roughly $2,893,406.
– RORY HARVEY, the Executive Vice President, has carried out 0 purchases and 4 sales, divesting 28,436 shares for about $1,538,349.

Looking at the hedge fund activity surrounding $GM, we note that 507 institutional investors have increased their positions in $GM stock, while 836 have decreased their holdings in the most recent quarter. Noteworthy among these recent shifts are:

– VANGUARD GROUP INC added 11,418,367 shares (+11.5%) to their portfolio in Q2 2025, valued at an estimated $561,897,840.
– VIKING GLOBAL INVESTORS LP added 5,830,050 shares (+81.1%) to their portfolio in Q2 2025, with an estimated value of $286,896,760.
– BLACKROCK, INC. reduced their holdings by 5,822,259 shares (-6.3%) in Q2 2025, resulting in a decrease in their portfolio worth $286,513,365.
– ARROWSTREET CAPITAL, LIMITED PARTNERSHIP also downsized their position, removing 4,745,608 shares (-50.2%) from their portfolio in Q2 2025, amounting to an estimated $233,531,369.
– HARRIS ASSOCIATES L P also decreased their shares, selling off 4,365,899 shares (-14.7%) in Q2 2025, with an estimated value of $214,845,889.

Looking at congressional stock trading activities related to $GM, we observe that members of Congress have engaged in 2 transactions over the past 6 months. These trades have involved 1 purchase and 1 sale, with the following breakdown:

– REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 worth of $GM stock on 05/12.
– REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 worth of $GM stock on 04/08.

In terms of analyst ratings on $GM, Wall Street analysts have provided buy ratings on the stock, with a smaller number issuing sell ratings. Over the past several months, analysts have issued varying reports, including:

– UBS issued a “Buy” rating on 09/24/2025.
– Citigroup issued a “Buy” rating on 09/22/2025.
– Wedbush issued an “Outperform” rating on 08/19/2025.
– Wells Fargo issued an “Underweight” rating on 07/23/2025.
– B of A Securities issued a “Buy” rating on 07/23/2025.
– JP Morgan issued an “Overweight” rating on 07/21/2025.
– Benchmark issued a “Buy” rating on 07/21/2025.

Moreover, market analysts have set price targets for $GM stock, with a median target of $63.0. Some recent targets include:

– Joseph Spak from UBS set a target price of $81.0 on 09/24/2025.
– Vijay Rakesh from Mizuho set a target price of $67.0 on 09/23/2025.
– Michael Ward from Citigroup set a target price of $75.0 on 09/22/2025.
– Dan Levy from Barclays set a target price of $73.0 on 09/12